−0.10TWD
−43.82 MTWD
1.03 MTWD
About MERCURY BIOPHARMACEUTICAL CORPORATI
Sector
Headquarters
New Taipei City
Founded
2019
Website
ISIN
TW0006932007
FIGI
BBG01BYYBXR8
Mercury Biopharmaceutical Corp. manufactures pharmaceutical products. It focuses on the development of drugs for unmet medical needs. It develop faster, lower side effects, and more in line with human needs for drugs. The company was founded in 2019 and is headquartered in New Taipei City. Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6932 is 15.30 TWD — it has decreased by 2.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange MERCURY BIOPHARMACEUTICAL CORPORATI stocks are traded under the ticker 6932.
6932 stock is 4.32% volatile and has beta coefficient of −0.62. Check out the list of the most volatile stocks — is MERCURY BIOPHARMACEUTICAL CORPORATI there?
Yes, you can track MERCURY BIOPHARMACEUTICAL CORPORATI financials in yearly and quarterly reports right on TradingView.
6932 stock has fallen by 4.67% compared to the previous week, the month change is a 3.77% fall, over the last year MERCURY BIOPHARMACEUTICAL CORPORATI has showed a 40.93% decrease.
6932 net income for the last quarter is −25.11 M TWD, while the quarter before that showed −18.71 M TWD of net income which accounts for −34.25% change. Track more MERCURY BIOPHARMACEUTICAL CORPORATI financial stats to get the full picture.
No, 6932 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6932 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MERCURY BIOPHARMACEUTICAL CORPORATI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MERCURY BIOPHARMACEUTICAL CORPORATI technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MERCURY BIOPHARMACEUTICAL CORPORATI stock shows the strong sell signal. See more of MERCURY BIOPHARMACEUTICAL CORPORATI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MERCURY BIOPHARMACEUTICAL CORPORATI EBITDA is −41.62 M TWD, and current EBITDA margin is −4.03 K%. See more stats in MERCURY BIOPHARMACEUTICAL CORPORATI financial statements.